VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S.

enVista Envy full range of vision intraocular lens (IOL) met all primary efficacy and safety endpoints in multicenter study Results show that enVista Envy IOLs deliver excellent visual performance, ...

Please provide your email address to receive an email when new articles are posted on . The enVista is a monofocal aberration-free IOL. Vision outcomes were better in patients who previously underwent ...

Please provide your email address to receive an email when new articles are posted on . The enVista toric IOL has improved material and design. It unfolds better and remains stable in the eye. SAN ...

Bausch + Lomb has announced it has received FDA approval for the enVista hydrophobic acrylic intraocular lens, according to a news release. Bausch + Lomb’s said it is the only FDA-approved IOL in the ...

Bausch + Lomb's received approval from the Food and Drug Administration for enVista Envy's full range of vision intraocular lens. The Canadian eye-health company said enVista offers a continuous range ...

Bausch + Lomb has recalled lenses used during cataract surgery due to complications when the lenses are used, according to an announcement from the Canada-based eyecare company posted on the U.S. Food ...

Bausch + Lomb, has announced the launch of its new enVista TORIC intraocular lens, according to a news release. The enVista TORIC is the company’s first hydrophobic acrylic IOL for astigmatism ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the American Journal of Ophthalmology has ...